MAXIMIZING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY PROVIDERS AND RAS ASSAYS

while in the promptly evolving area of oncology research, precise and productive mutation screening is very important for creating qualified therapies. The KRAS products and services Platform plays a pivotal function On this landscape by providing complete solutions for KRAS mutation profiling and Assessment. KRAS mutations, present in close to 95%